3 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Head Injuries, Closed: new trials by email Literature Review of Head Injuries, Closed trials Research Report on Head Injuries, Closed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion 50 Adipose Derived Stem Cell Infusion, 150 Adipose Derived Stem Cell Infusion, 300 Adipose Derived Stem Cell Infusion - Post-Concussion Syndrome | Phase 1 | Unknown | American CryoStem Corporation | 20 | 2021-02-01 | 2023-06-09 |
| Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury AbelaDrug200, mannitol - Severe Head Trauma | Phase 1 / Phase 2 | Unknown | Abela Pharmaceuticals, Inc. | 30 | 2010-10-01 | 2010-12-08 |
| Problems With Morphine Use in Patients With a Severe Brain Injury morphine - Head Trauma, Subarachnoid Hemorrhage | Phase 1 / Phase 2 | Unknown | Dalhousie University | 20 | 2005-01-01 | 2008-04-10 |
Brain Injuries, Traumatic (2) · Craniocerebral Trauma (2) · Brain Concussion (1) · Post-Concussion Syndrome (1) · Subarachnoid Hemorrhage (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Wounds, Nonpenetrating (3) · Brain Injuries (2) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Craniocerebral Trauma (1) · Hemorrhage (1) · Intracranial Hemorrhages (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Abela Pharmaceuticals, Inc. (1) · American CryoStem Corporation (1) · Dalhousie University (1)
United States (2) · Canada (1)
Peter B Hanson, MD (1) · Richard I Hall, MD (1)